IOWA ONCOLOGY RESEARCH ASSOCIATION
[ Home ] [ Treatment ] [ Control & Prevention ] [ STAR ] [ SELECT ] [ Physicians ] [ Contact Us ] [ Helpful Links ]

Head and Neck Cancer Research Studies

METASTATIC / RECURRENT
E1302    Phase III Randomized, Placebo Controlled, Trial of Docetaxel Versus Docetaxel Plus ZD1839 (IRESSA) in Performance Status 2 or Previously Treated Patients with Recurrent or Metastatic Head and Neck Cancer

E1304   Phase II Two Arm Trial of the Proteasome Inhibitor, PS-341 (VELCADE™) in Combination with Irinotecan or PS-341 Alone Followed by the Addition of Irinotecan at Time of Progression in Patients with Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)